Item 2.02. Results of Operations and Financial Condition.

On March 25, 2020, Arcadia Biosciences, Inc. (the "Company") issued a press release announcing financial results for the fourth quarter and year ended December 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Form 8-K and the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the press release attached as Exhibit 99.1 shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.




Exhibit No.                                  Description

99.1            Arcadia Biosciences Announces Fourth-Quarter and Full Year 2019
              Financial Results and Business Highlights

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses